Holdings
中国远大集团有限责任公司
As of May 15, 2026, 中国远大集团有限责任公司 reported 2 positions. Largest: Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H and Qyuns Therapeutics Co., Ltd. Class H. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H | 42.1M | first report | May 15, 2026 | |
| Qyuns Therapeutics Co., Ltd. Class H | 37.9M | first report | Aug 25, 2025 |